Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial.
Knops RE, Pepplinkhuizen S, Delnoy PPHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, Kaab S, Mittal S, Quast ABE, van der Stuijt W, Smeding L, de Veld JA, Tijssen JGP, Bijsterveld NR, Richter S, Brouwer MA, de Groot JR, Kooiman KM, Lambiase PD, Neuzil P, Vernooy K, Alings M, Betts TR, Bracke FALE, Burke MC, de Jong JSSG, Wright DJ, Jansen WPJ, Whinnett ZI, Nordbeck P, Knaut M, Philbert BT, van Opstal JM, Chicos AB, Allaart CP, Borger van der Burg AE, Dizon JM, Miller MA, Nemirovsky D, Surber R, Upadhyay GA, Weiss R, de Weger A, Wilde AAM, Olde Nordkamp LRA. Knops RE, et al. Among authors: bijsterveld nr. Eur Heart J. 2022 Dec 14;43(47):4872-4883. doi: 10.1093/eurheartj/ehac496. Eur Heart J. 2022. PMID: 36030464 Free PMC article. Clinical Trial.
Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies.
Bijsterveld NR, Peters RJ, Murphy SA, Bernink PJ, Tijssen JG, Cohen M. Bijsterveld NR, et al. J Am Coll Cardiol. 2003 Dec 17;42(12):2083-9. doi: 10.1016/j.jacc.2003.05.014. J Am Coll Cardiol. 2003. PMID: 14680731 Clinical Trial.
Subcutaneous or Transvenous Defibrillator Therapy.
Knops RE, Olde Nordkamp LRA, Delnoy PHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, Kääb S, Mittal S, Quast ABE, Smeding L, van der Stuijt W, de Weger A, de Wilde KC, Bijsterveld NR, Richter S, Brouwer MA, de Groot JR, Kooiman KM, Lambiase PD, Neuzil P, Vernooy K, Alings M, Betts TR, Bracke FALE, Burke MC, de Jong JSSG, Wright DJ, Tijssen JGP, Wilde AAM; PRAETORIAN Investigators. Knops RE, et al. Among authors: bijsterveld nr. N Engl J Med. 2020 Aug 6;383(6):526-536. doi: 10.1056/NEJMoa1915932. N Engl J Med. 2020. PMID: 32757521 Clinical Trial.
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death.
Verstraelen TE, van Barreveld M, van Dessel PHFM, Boersma LVA, Delnoy PPHM, Tuinenburg AE, Theuns DAMJ, van der Voort PH, Kimman GP, Buskens E, Hulleman M, Allaart CP, Strikwerda S, Scholten MF, Meine M, Abels R, Maass AH, Firouzi M, Widdershoven JWMG, Elders J, van Gent MWF, Khan M, Vernooy K, Grauss RW, Tukkie R, van Erven L, Spierenburg HAM, Brouwer MA, Bartels GL, Bijsterveld NR, Borger van der Burg AE, Vet MW, Derksen R, Knops RE, Bracke FALE, Harden M, Sticherling C, Willems R, Friede T, Zabel M, Dijkgraaf MGW, Zwinderman AH, Wilde AAM. Verstraelen TE, et al. Among authors: bijsterveld nr. Europace. 2021 Jun 7;23(6):887-897. doi: 10.1093/europace/euab012. Europace. 2021. PMID: 33582797 Free PMC article.
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
Knops RE, van der Stuijt W, Delnoy PPHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, Kääb S, Mittal S, Quast ABE, Smeding L, Tijssen JGP, Bijsterveld NR, Richter S, Brouwer MA, de Groot JR, Kooiman KM, Lambiase PD, Neuzil P, Vernooy K, Alings M, Betts TR, Bracke FALE, Burke MC, de Jong JSSG, Wright DJ, Jansen WPJ, Whinnet ZI, Nordbeck P, Knaut M, Philbert BT, van Opstal JM, Chicos AB, Allaart CP, Borger van der Burg AE, Clancy JF, Dizon JM, Miller MA, Nemirovsky D, Surber R, Upadhyay GA, Weiss R, de Weger A, Wilde AAM, Olde Nordkamp LRA; PRAETORIAN Investigators‡. Knops RE, et al. Among authors: bijsterveld nr. Circulation. 2022 Feb;145(5):321-329. doi: 10.1161/CIRCULATIONAHA.121.057816. Epub 2021 Nov 14. Circulation. 2022. PMID: 34779221 Free article. Clinical Trial.
Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator?
van der Stuijt W, Pepplinkhuizen S, de Veld JA, Quast ABE, van Halm VP, Bijsterveld NR, Olde Nordkamp LRA, Wilde AAM, Smeding L, Knops RE. van der Stuijt W, et al. Among authors: bijsterveld nr. Int J Cardiol. 2024 Mar 1;398:131639. doi: 10.1016/j.ijcard.2023.131639. Epub 2023 Dec 7. Int J Cardiol. 2024. PMID: 38065323 Free article.
Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry.
Erküner Ö, van Eck M, Xhaet O, Verheij H, Neefs J, Duygun A, Nijmeijer R, Saïd SAM, Uiterwaal H, Hagens V, Bhagwandien R, Szili-Torok T, Bijsterveld N, Tjeerdsma G, Vijgen J, Friart A, Hoffer E, Evrard P, Srynger M, Meeder J, de Groot JR, van Opstal J, Gevers R, Lip GYH, Boriani G, Crijns HJGM, Luermans JGLM, Mairesse GH. Erküner Ö, et al. Neth Heart J. 2021 Nov;29(11):584-594. doi: 10.1007/s12471-021-01634-y. Epub 2021 Sep 15. Neth Heart J. 2021. PMID: 34524620 Free PMC article.
37 results